Search for a command to run...
Promoters increased their stake by 12.34% YoY, indicating strong insider confidence in Eiko Lifesciences Ltd.
Institutional shareholding remained unchanged, contrasting with sector averages where no changes occurred, highlighting a divergence in sentiment.
Public shareholding declined by 12.39% YoY, suggesting retail investors are selling, potentially creating a buying opportunity for long-term investors.
| Category | Trend | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter Holdings | 24.23% | 24.23% | 24.4% | 24.4% | 31.27% | 36.23% | 37.11% | 37.17% | |
2Public Holdings | 75.77% | 75.77% | 75.6% | 75.6% | 68.73% | 63.77% | 62.89% | 62.83% | |
3Foreign Investors | - | - | - | - | - | - | - | - | |
4Domestic Investors | - | - | - | - | - | - | - | - |